About
Eric De La Fortelle is Head of Business Development and Strategy at the Institute of Molecular and Clinical Ophthalmology Basel. He has held roles across scientific research, biotech, pharma, and venture capital, with experience in project evaluation, innovation management, and startup governance.
Experience
- Institute of Molecular and Clinical Ophthalmology Basel (IOB)Head of Business Development and Strategycurrent2025 — present
- Cathay HealthManaging Partnercurrent2021 — presentParis - Basel
- Ganymed RoboticsBoard Membercurrent2022 — presentParis, Île-de-France, France
- Health Opportunities GmbHManaging Directorcurrent2014 — presentBasel, Switzerland
- SENSORIONIndependent Board Directorcurrent2015 — presentGreater Montpellier Metropolitan Area
- SENSORIONChairman of the Board of Directors2014 — 2015Greater Montpellier Metropolitan Area
- SENSORIONSupervisory Board Director2012 — 2013Greater Montpellier Metropolitan Area
- Kojin TherapeuticsBoard member representingi Cathay Health2023 — 2025Cambridge, Massachusetts, United States
- IOME BIOBoard Member2021Colmar, Grand Est, France
- Dermala Inc.Board member2020 — 2021San Diego, California, United States
- Siolta TherapeuticsBoard Member2020 — 2021
- Siolta TherapeuticsBoard Observer2019 — 2021San Francisco Bay Area
- Axial Biotherapeutics, Inc.Board Member2019 — 2021Greater Boston
- LiMM TherapeuticsBoard Member2018 — 2021Paris and Lisbon
- A-Mansia Biotech SABoard Director2018 — 2021Bruxelles, Belgium
- DayTwo Ltd.Board Observer2017 — 2021Tel Aviv District, Israel
- Seventure PartnersVenture Partner2014 — 2021Basel, Switzerland
- TargEDysBoard Director2016 — 2020
- MaaT PharmaBoard Director2014 — 2020Lyon, France
- Mint Solutions - MedEyeBoard Director2014 — 2020The Randstad, Netherlands
Education
- INSEADMBA, Finance1999
- Paris-Sud University (Paris XI)PhD, Biophysics1990 — 1994
- IFSBM (Institut de Formation Supérieure Biomédicale)Doctoral Degree, Medical Sciences1990 — 1993
- CentraleSupélecIngénieur de l'Ecole Centrale Paris (MSc, Physics)1987 — 1990
- Lycée Privé Sainte-Geneviève1985 — 1987
Skills & more
Valuation33Contract Negotiation47Drug Discovery99Technology Transfer97Business Alliances43Biotechnology32Clinical Trials18Antibodies7Start-ups13Strategic Alliances1Biochemistry4Business Strategy15
+12 more
Corporate DevelopmentVenture CapitalLifesciencesOncologyProtein ChemistryLife SciencesBiopharmaceuticalsDrug DevelopmentStrategyManagementLeadershipBiomarkersFrom Eric's professional profile.
Same school
Also attended INSEAD697
Patrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesStephane KurganInvestor at Index VenturesMahesha SubramaniamHead of Client Relations at Golden Gate Ventures
+ 691 more
Also attended Paris-Sud University (Paris XI)14
Louis DussartVP, Europe at RTP GlobalThierry LaugelManaging Partner at Kurma PartnersClement SalqueAssociate at Bioqube VenturesMaria Emilie Kath DanøManaging Partner at PSV Hafnium at PSVAmir BanifatemiManaging Partner at K5 VenturesMohamed DiabakhateData Engineer at Digital Africa
+ 8 more
Also attended CentraleSupélec75
Pierre GalletInvestor at DaphniSalim HassadPartner at Newfund CapitalBenjamin AuschitzkyScaleup Success Manager at Partech VenturesVictor HubersonPrincipal at Partech VenturesAlison ImbertPartner at Partech VenturesJean-Marc PatouillaudFounding Partner & Senior Advisor at Partech Ventures
+ 69 more
Shared employers
Also worked at Siolta Therapeutics1
Also worked at Axial Biotherapeutics, Inc.3
Also worked at DayTwo Ltd.3
Also worked at BiomX Ltd2
Deals · 5
Ascend Advanced TherapiesSolo GP
via Cathay Health
Moon SurgicalSolo GP
via Cathay Health
TissiumSolo GP
via Cathay Health
Ganymed RoboticsSolo GP
via Cathay Health
Initiate StudioSolo GP
via Cathay Health
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.


.jpg)



%20(1).png)




















